Cipla receives two observations following USFDA inspection at Goa facility
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Muted movement reflects consolidation phase as investors await earnings triggers
The investment case for health technology in India is frequently overstated in one direction and understated in another
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
AI-enabled women’s digital clinic brings in-person consultations to complement app-led care after serving over 400,000 women across India
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
Divestment marks Redcliffe’s strategic pivot toward preventive and advanced diagnostics; Crysta IVF to continue under existing leadership
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
API maker begins circulation of second and final call money notice for partly paid-up rights shares, completing the last leg of its 2024 fundraising cycle
Subscribe To Our Newsletter & Stay Updated